Braveheart Bio, Inc.
BRVE
14 insider filings · Latest: Aug 7, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 11 9:53 PM | AH Bio Fund IV, L.P.10% Owner | Purchase | 1,100,000 | $18.00 | $19.8M | 10,232,420(I) | View → |
| Aug 7, 2026 | Aug 11 9:31 PM | Erez ChimovitsDirector, 10% Owner | Purchase | 1,940,000 | $18.00 | $34.9M | 273,333(I) | View → |
| Aug 7, 2026 | Aug 11 9:27 PM | ORBIMED ADVISORS LLCDirector, 10% Owner | Purchase | 1,940,000 | $18.00 | $34.9M | 273,333(I) | View → |
| Aug 7, 2026 | Aug 7 9:25 PM | Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner | Purchase | 3,600,000 | $18.00 | $64.8M | 10,185,478(I) | View → |
| Aug 7, 2026 | Aug 7 8:41 PM | James Paul RickeyChief Financial Officer | Purchase | 27,777 | $18.00 | $500.0K | 520,927(D) | View → |
| Aug 7, 2026 | Aug 7 8:31 PM | Christopher ViehbacherDirector | Purchase | 83,333 | $18.00 | $1.5M | 609,519(D) | View → |
| Aug 7, 2026 | Aug 7 8:31 PM | David I MalekDirector | Purchase | 4,166 | $18.00 | $75.0K | 533,845(D) | View → |
| Aug 7, 2026 | Aug 7 8:30 PM | Michele A. AndersonChief Development Officer | Purchase | 1,111 | $18.00 | $20.0K | 332,161(D) | View → |
| Aug 7, 2026 | Aug 7 8:30 PM | Travis MurdochDirector, CEO and President | Purchase | 83,333 | $18.00 | $1.5M | 2,940,670(D) | View → |
| Aug 7, 2026 | Aug 7 8:30 PM | David Charles LubnerDirector | Purchase | 55,555 | $18.00 | $1000.0K | 55,555(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Aug 11 9:53 PM | AH Bio Fund IV, L.P.10% Owner | Conversion | 40,000,000 | — | 0(I) | View → |
| Aug 7, 2026 | Aug 11 9:31 PM | Erez ChimovitsDirector, 10% Owner | Conversion | 40,000,000 | — | 0(I) | View → |
| Aug 7, 2026 | Aug 11 9:27 PM | ORBIMED ADVISORS LLCDirector, 10% Owner | Conversion | 40,000,000 | — | 0(I) | View → |
| Aug 7, 2026 | Aug 10 2:03 PM | Jiangsu Hengrui Pharmaceuticals Co., Ltd.10% Owner | Conversion | 32,500,000 | — | 0(D) | View → |
| Aug 7, 2026 | Aug 7 9:25 PM | Forbion Growth Opportunities Fund III Cooperatief U.A.10% Owner | Conversion | 75,000,000 | — | 0(I) | View → |
| Aug 5, 2026 | Aug 7 8:41 PM | James Paul RickeyChief Financial Officer | Grant/Award | 300,000 | $18.00 | 300,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:41 PM | Tim LohoffDirector | Grant/Award | 30,000 | $18.00 | 30,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:31 PM | Erez ChimovitsDirector, 10% Owner | Grant/Award | 30,000 | $18.00 | 30,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:31 PM | Christopher ViehbacherDirector | Grant/Award | 30,000 | $18.00 | 30,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:31 PM | David I MalekDirector | Grant/Award | 30,000 | $18.00 | 30,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:30 PM | Michele A. AndersonChief Development Officer | Grant/Award | 300,000 | $18.00 | 300,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:30 PM | Travis MurdochDirector, CEO and President | Grant/Award | 550,000 | $19.80 | 550,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:30 PM | Jasper BosDirector | Grant/Award | 30,000 | $18.00 | 30,000(D) | View → |
| Aug 5, 2026 | Aug 7 8:30 PM | David Charles LubnerDirector | Grant/Award | 60,000 | $18.00 | 60,000(D) | View → |